Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

8.61  -0.05 (-0.58%)

After market: 8.7395 +0.13 (+1.5%)

Fundamental Rating

3

Taking everything into account, BLMN scores 3 out of 10 in our fundamental rating. BLMN was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. While BLMN is still in line with the averages on profitability rating, there are concerns on its financial health. BLMN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BLMN had positive earnings in the past year.
In the past year BLMN had a positive cash flow from operations.
In multiple years BLMN reported negative net income over the last 5 years.
Each year in the past 5 years BLMN had a positive operating cash flow.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BLMN's Return On Assets of -0.06% is on the low side compared to the rest of the industry. BLMN is outperformed by 63.16% of its industry peers.
The Return On Equity of BLMN (-0.52%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 5.46%, BLMN is in line with its industry, outperforming 50.38% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BLMN is below the industry average of 13.81%.
The 3 year average ROIC (9.55%) for BLMN is well above the current ROIC(5.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROIC 5.46%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLMN has a Operating Margin of 4.59%. This is in the lower half of the industry: BLMN underperforms 64.66% of its industry peers.
In the last couple of years the Operating Margin of BLMN has grown nicely.
BLMN's Gross Margin of 71.00% is amongst the best of the industry. BLMN outperforms 85.71% of its industry peers.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 4.59%
PM (TTM) N/A
GM 71%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
BLMN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
The debt/assets ratio for BLMN is higher compared to a year ago.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.94, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLMN (0.94) is worse than 69.17% of its industry peers.
The Debt to FCF ratio of BLMN is 35.06, which is on the high side as it means it would take BLMN, 35.06 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 35.06, BLMN perfoms like the industry average, outperforming 41.35% of the companies in the same industry.
BLMN has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.41, BLMN is in line with its industry, outperforming 48.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Altman-Z 0.94
ROIC/WACC0.71
WACC7.64%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

BLMN has a Current Ratio of 0.41. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BLMN (0.41) is worse than 81.20% of its industry peers.
BLMN has a Quick Ratio of 0.41. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN's Quick ratio of 0.33 is on the low side compared to the rest of the industry. BLMN is outperformed by 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.33
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -35.74% in the last year.
The Earnings Per Share has been growing slightly by 3.30% on average over the past years.
Looking at the last year, BLMN shows a very negative growth in Revenue. The Revenue has decreased by -17.68% in the last year.
BLMN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.93% yearly.
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%

3.2 Future

The Earnings Per Share is expected to decrease by -8.14% on average over the next years.
Based on estimates for the next years, BLMN will show a decrease in Revenue. The Revenue will decrease by -2.88% on average per year.
EPS Next Y-32.07%
EPS Next 2Y-15.87%
EPS Next 3Y-8.14%
EPS Next 5YN/A
Revenue Next Year-11.48%
Revenue Next 2Y-5.19%
Revenue Next 3Y-2.88%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.09 indicates a rather cheap valuation of BLMN.
97.74% of the companies in the same industry are more expensive than BLMN, based on the Price/Earnings ratio.
BLMN is valuated cheaply when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
BLMN is valuated cheaply with a Price/Forward Earnings ratio of 6.76.
93.98% of the companies in the same industry are more expensive than BLMN, based on the Price/Forward Earnings ratio.
BLMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.09
Fwd PE 6.76
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLMN is valued cheaply inside the industry as 95.49% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BLMN is valued a bit cheaper than 63.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.98
EV/EBITDA 4.63
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

BLMN's earnings are expected to decrease with -8.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.54
EPS Next 2Y-15.87%
EPS Next 3Y-8.14%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.81%, BLMN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.71, BLMN pays a better dividend. On top of this BLMN pays more dividend than 95.49% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.81%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BLMN are negative and hence is the payout ratio. BLMN will probably not be able to sustain this dividend level.
DP-3723.47%
EPS Next 2Y-15.87%
EPS Next 3Y-8.14%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (6/30/2025, 5:20:01 PM)

After market: 8.7395 +0.13 (+1.5%)

8.61

-0.05 (-0.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-25 2025-07-25/bmo
Inst Owners103.97%
Inst Owner Change0.6%
Ins Owners1.65%
Ins Owner Change7.09%
Market Cap732.37M
Analysts54.44
Price Target8.97 (4.18%)
Short Float %10.43%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 6.81%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-3723.47%
Div Incr Years0
Div Non Decr Years2
Ex-Date05-20 2025-05-20 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.32%
Min EPS beat(2)2.96%
Max EPS beat(2)3.69%
EPS beat(4)3
Avg EPS beat(4)-1.61%
Min EPS beat(4)-13.76%
Max EPS beat(4)3.69%
EPS beat(8)6
Avg EPS beat(8)1.23%
EPS beat(12)10
Avg EPS beat(12)2.7%
EPS beat(16)13
Avg EPS beat(16)4.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)-0.32%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-2.62%
Max Revenue beat(4)-0.32%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)3
Avg Revenue beat(16)-1.56%
PT rev (1m)-10.21%
PT rev (3m)-30.79%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-31.7%
EPS NY rev (1m)-2.31%
EPS NY rev (3m)-8.02%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 5.09
Fwd PE 6.76
P/S 0.19
P/FCF 27.98
P/OCF 3.21
P/B 1.92
P/tB N/A
EV/EBITDA 4.63
EPS(TTM)1.69
EY19.63%
EPS(NY)1.27
Fwd EY14.8%
FCF(TTM)0.31
FCFY3.57%
OCF(TTM)2.68
OCFY31.11%
SpS44.73
BVpS4.47
TBVpS-3.07
PEG (NY)N/A
PEG (5Y)1.54
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.58%
ROICexgc 7.54%
OM 4.59%
PM (TTM) N/A
GM 71%
FCFM 0.69%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Debt/EBITDA 2.66
Cap/Depr 118.44%
Cap/Sales 5.3%
Interest Coverage 2.88
Cash Conversion 66.07%
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.33
Altman-Z 0.94
F-Score6
WACC7.64%
ROIC/WACC0.71
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
EPS Next Y-32.07%
EPS Next 2Y-15.87%
EPS Next 3Y-8.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%
Revenue Next Year-11.48%
Revenue Next 2Y-5.19%
Revenue Next 3Y-2.88%
Revenue Next 5YN/A
EBIT growth 1Y-46.89%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.37%
EBIT Next 3Y11.73%
EBIT Next 5YN/A
FCF growth 1Y-86.19%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-47.45%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%